Andréanne Côté

Médecin en soins palliatifs
CIUSSS du Nord-de-l’Île-de-Montréal

Professeure adjointe de clinique
Département de médecine de famille et médecine d’urgence, Université de Montréal

Andréanne Côté est médecin en soins palliatifs dans le CIUSSS du Nord-de-l'Île-de-Montréal, en soins à domicile et en pratique hospitalière. Elle est également impliquée à l'Université de Montréal comme directrice de programme de compétences avancées en soins palliatifs. Elle possède une maîtrise en sciences des religions (concentration en études sur la mort) durant laquelle elle s'est intéressée aux approches complémentaires en santé. Elle compte à son actif des présentations dans des congrès d'envergure nationale et internationale et publie des articles en lien avec ses champs d'intérêt dans des revues avec et sans comité de pairs. Elle collabore à des projets de recherche touchant au domaine des soins palliatifs et a récemment obtenu des subventions pour son plus récent projet intitulé Les soins palliatifs en scène. Pour souligner son implication dans l'enseignement pré-gradué, elle a reçu le prix pour l'enseignement aux études médicales du 1er cycle 2019 décerné par le département de médecine de famille et de médecine d'urgence de l'Université de Montréal.

Publications

8435569 Andréanne Côté 1 chicago-author-date 10 date desc 1 title https://rechercheciusssnim.ca/wp-content/plugins/zotpress/

%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22UZZUHULG%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mazzola%20et%20al.%22%2C%22parsedDate%22%3A%222025-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMazzola%2C%20Rosetta%2C%20Shawn%20D.%20Aaron%2C%20Katherine%20L.%20Vandemheen%2C%20et%20al.%202025.%20%26%23x201C%3BAssociation%20between%20Lung%20Function%20and%20Sleep%20Disorder%20Symptoms%20in%20a%20Community-Based%20Multi-Site%20Case-Finding%20Study.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Sleep%20Research%26lt%3B%5C%2Fi%26gt%3B%2034%20%283%29%3A%20e14356.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjsr.14356%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjsr.14356%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20between%20lung%20function%20and%20sleep%20disorder%20symptoms%20in%20a%20community-based%20multi-site%20case-finding%20study.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosetta%22%2C%22lastName%22%3A%22Mazzola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20D.%22%2C%22lastName%22%3A%22Aaron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20L.%22%2C%22lastName%22%3A%22Vandemheen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunita%22%2C%22lastName%22%3A%22Mulpuru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Celine%22%2C%22lastName%22%3A%22Bergeron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Lemi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22C%5Cu00f4t%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis-Philippe%22%2C%22lastName%22%3A%22Boulet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20K.%22%2C%22lastName%22%3A%22Field%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Penz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Andrew%22%2C%22lastName%22%3A%22McIvor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samir%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irvin%22%2C%22lastName%22%3A%22Mayers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohit%22%2C%22lastName%22%3A%22Bhutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Hernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Diane%22%2C%22lastName%22%3A%22Lougheed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%22%2C%22lastName%22%3A%22Licskai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanweer%22%2C%22lastName%22%3A%22Azher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Ezer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martha%22%2C%22lastName%22%3A%22Ainslie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tetyana%22%2C%22lastName%22%3A%22Kendzerska%22%7D%5D%2C%22abstractNote%22%3A%22Obstructive%20airway%20disease%20is%20associated%20with%20sleep%20disturbances.%20We%20aimed%20to%20assess%20the%20relationship%20between%20lung%20function%20and%20sleep%20disorder%20symptoms%20using%20%20cross-sectionally%20collected%20data%20between%20March%202017%20and%20August%202021%20from%20the%20%20Undiagnosed%20Chronic%20Obstructive%20Pulmonary%20Disease%20and%20Asthma%20Population%20study%2C%20a%20%20prospective%20community-based%20multi-site%20case-finding%20study.%20Undiagnosed%20Chronic%20%20Obstructive%20Pulmonary%20Disease%20and%20Asthma%20Population%20study%20participants%20with%20%20respiratory%20symptoms%20but%20without%20diagnosed%20lung%20disease%20who%20completed%20spirometry%20%20and%20the%20Global%20Sleep%20Assessment%20Questionnaire%20were%20included.%20We%20conducted%20%20multivariate%20linear%20regression%20models%20for%20forced%20expiratory%20volume%20in%201%5Cu2005s%2C%20forced%20%20vital%20capacity%20and%20forced%20expiratory%20volume%20in%201%5Cu2005s%5C%2Fforced%20vital%20capacity%20by%20%20Global%20Sleep%20Assessment%20Questionnaire%20responses%20adjusted%20for%20confounders.%20The%20%20same%20models%20were%20employed%20to%20examine%20respiratory%20symptoms%2C%20as%20reported%20on%20the%20St%20%20George%26%23039%3Bs%20Respiratory%20Questionnaire%20and%20Chronic%20Obstructive%20Pulmonary%20Disease%20%20Assessment%20Test%2C%20by%20Global%20Sleep%20Assessment%20Questionnaire%20responses.%20Logistic%20%20regression%20models%20were%20used%20to%20assess%20the%20association%20of%20undiagnosed%20obstructive%20%20airway%20disease%20with%20sleep%20symptoms.%20Amongst%202093%20adults%20included%20in%20the%20study%2C%20%2048.3%25%20were%20female%20and%20the%20median%20age%20was%2063%5Cu2009years%20%28interquartile%20range%2053-72%29.%20%20Two-hundred%20and%20five%20%289.79%25%29%20subjects%20met%20spirometry%20criteria%20for%20undiagnosed%20%20chronic%20obstructive%20pulmonary%20disease%2C%20and%20191%20%289.13%25%29%20for%20undiagnosed%20asthma.%20%20There%20were%20no%20significant%20associations%20between%20spirometry%20measures%20and%20sleep%20%20symptoms%20%28p%5Cu2009%26gt%3B%5Cu20090.5%29%2C%20controlling%20for%20age%2C%20sex%2C%20body%20mass%20index%2C%20smoking%20and%20%20comorbidities.%20Those%20with%20undiagnosed%20asthma%20were%20more%20likely%20to%20report%20insomnia%20%20%26quot%3Bat%20least%20sometimes%26quot%3B%20versus%20%26quot%3Bnever%26quot%3B%20%28odds%20ratio%202.58%2C%2095%25%20confidence%20interval%3A%20%201.27-6.19%2C%20p%5Cu2009%3D%5Cu20090.02%29.%20Respiratory%20symptoms%20were%20associated%20with%20sleep%20symptoms%2C%20%20with%20significant%20%28p%5Cu2009%26lt%3B%5Cu20090.05%29%20increases%20in%20St%20George%26%23039%3Bs%20Respiratory%20Questionnaire%20%20and%20Chronic%20Obstructive%20Pulmonary%20Disease%20Assessment%20Test%20scores%20in%20those%20%20reporting%20most%20sleep%20symptoms.%20Overall%2C%20we%20found%20an%20association%20between%20%20undiagnosed%20asthma%20and%20insomnia%2C%20and%20between%20respiratory%20and%20sleep%20disorder%20%20symptoms.%22%2C%22date%22%3A%222025%20Jun%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fjsr.14356%22%2C%22ISSN%22%3A%221365-2869%200962-1105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DUYH96TL%22%5D%2C%22dateModified%22%3A%222025-05-23T13%3A40%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22WD4Y86LN%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mazzola%20et%20al.%22%2C%22parsedDate%22%3A%222025-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMazzola%2C%20Rosetta%2C%20Shawn%20D.%20Aaron%2C%20Katherine%20L.%20Vandemheen%2C%20et%20al.%202025.%20%26%23x201C%3BAssociation%20between%20Lung%20Function%20and%20Sleep%20Disorder%20Symptoms%20in%20a%20Community-Based%20Multi-Site%20Case-Finding%20Study.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Sleep%20Research%26lt%3B%5C%2Fi%26gt%3B%2034%20%283%29%3A%20e14356.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjsr.14356%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjsr.14356%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20between%20lung%20function%20and%20sleep%20disorder%20symptoms%20in%20a%20community-based%20multi-site%20case-finding%20study.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosetta%22%2C%22lastName%22%3A%22Mazzola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20D.%22%2C%22lastName%22%3A%22Aaron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20L.%22%2C%22lastName%22%3A%22Vandemheen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunita%22%2C%22lastName%22%3A%22Mulpuru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Celine%22%2C%22lastName%22%3A%22Bergeron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Lemi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22C%5Cu00f4t%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis-Philippe%22%2C%22lastName%22%3A%22Boulet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20K.%22%2C%22lastName%22%3A%22Field%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Penz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Andrew%22%2C%22lastName%22%3A%22McIvor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samir%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irvin%22%2C%22lastName%22%3A%22Mayers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohit%22%2C%22lastName%22%3A%22Bhutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Hernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Diane%22%2C%22lastName%22%3A%22Lougheed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%22%2C%22lastName%22%3A%22Licskai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanweer%22%2C%22lastName%22%3A%22Azher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Ezer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martha%22%2C%22lastName%22%3A%22Ainslie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tetyana%22%2C%22lastName%22%3A%22Kendzerska%22%7D%5D%2C%22abstractNote%22%3A%22Obstructive%20airway%20disease%20is%20associated%20with%20sleep%20disturbances.%20We%20aimed%20to%20assess%20the%20relationship%20between%20lung%20function%20and%20sleep%20disorder%20symptoms%20using%20%20cross-sectionally%20collected%20data%20between%20March%202017%20and%20August%202021%20from%20the%20%20Undiagnosed%20Chronic%20Obstructive%20Pulmonary%20Disease%20and%20Asthma%20Population%20study%2C%20a%20%20prospective%20community-based%20multi-site%20case-finding%20study.%20Undiagnosed%20Chronic%20%20Obstructive%20Pulmonary%20Disease%20and%20Asthma%20Population%20study%20participants%20with%20%20respiratory%20symptoms%20but%20without%20diagnosed%20lung%20disease%20who%20completed%20spirometry%20%20and%20the%20Global%20Sleep%20Assessment%20Questionnaire%20were%20included.%20We%20conducted%20%20multivariate%20linear%20regression%20models%20for%20forced%20expiratory%20volume%20in%201%5Cu2005s%2C%20forced%20%20vital%20capacity%20and%20forced%20expiratory%20volume%20in%201%5Cu2005s%5C%2Fforced%20vital%20capacity%20by%20%20Global%20Sleep%20Assessment%20Questionnaire%20responses%20adjusted%20for%20confounders.%20The%20%20same%20models%20were%20employed%20to%20examine%20respiratory%20symptoms%2C%20as%20reported%20on%20the%20St%20%20George%26%23039%3Bs%20Respiratory%20Questionnaire%20and%20Chronic%20Obstructive%20Pulmonary%20Disease%20%20Assessment%20Test%2C%20by%20Global%20Sleep%20Assessment%20Questionnaire%20responses.%20Logistic%20%20regression%20models%20were%20used%20to%20assess%20the%20association%20of%20undiagnosed%20obstructive%20%20airway%20disease%20with%20sleep%20symptoms.%20Amongst%202093%20adults%20included%20in%20the%20study%2C%20%2048.3%25%20were%20female%20and%20the%20median%20age%20was%2063%5Cu2009years%20%28interquartile%20range%2053-72%29.%20%20Two-hundred%20and%20five%20%289.79%25%29%20subjects%20met%20spirometry%20criteria%20for%20undiagnosed%20%20chronic%20obstructive%20pulmonary%20disease%2C%20and%20191%20%289.13%25%29%20for%20undiagnosed%20asthma.%20%20There%20were%20no%20significant%20associations%20between%20spirometry%20measures%20and%20sleep%20%20symptoms%20%28p%5Cu2009%26gt%3B%5Cu20090.5%29%2C%20controlling%20for%20age%2C%20sex%2C%20body%20mass%20index%2C%20smoking%20and%20%20comorbidities.%20Those%20with%20undiagnosed%20asthma%20were%20more%20likely%20to%20report%20insomnia%20%20%26quot%3Bat%20least%20sometimes%26quot%3B%20versus%20%26quot%3Bnever%26quot%3B%20%28odds%20ratio%202.58%2C%2095%25%20confidence%20interval%3A%20%201.27-6.19%2C%20p%5Cu2009%3D%5Cu20090.02%29.%20Respiratory%20symptoms%20were%20associated%20with%20sleep%20symptoms%2C%20%20with%20significant%20%28p%5Cu2009%26lt%3B%5Cu20090.05%29%20increases%20in%20St%20George%26%23039%3Bs%20Respiratory%20Questionnaire%20%20and%20Chronic%20Obstructive%20Pulmonary%20Disease%20Assessment%20Test%20scores%20in%20those%20%20reporting%20most%20sleep%20symptoms.%20Overall%2C%20we%20found%20an%20association%20between%20%20undiagnosed%20asthma%20and%20insomnia%2C%20and%20between%20respiratory%20and%20sleep%20disorder%20%20symptoms.%22%2C%22date%22%3A%222025%20Jun%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fjsr.14356%22%2C%22ISSN%22%3A%221365-2869%200962-1105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-23T13%3A37%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22ZC56RW45%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mazzola%20et%20al.%22%2C%22parsedDate%22%3A%222025-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMazzola%2C%20Rosetta%2C%20Shawn%20D.%20Aaron%2C%20Katherine%20L.%20Vandemheen%2C%20et%20al.%202025.%20%26%23x201C%3BAssociation%20between%20Lung%20Function%20and%20Sleep%20Disorder%20Symptoms%20in%20a%20Community-Based%20Multi-Site%20Case-Finding%20Study.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Sleep%20Research%26lt%3B%5C%2Fi%26gt%3B%2034%20%283%29%3A%20e14356.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjsr.14356%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjsr.14356%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20between%20lung%20function%20and%20sleep%20disorder%20symptoms%20in%20a%20community-based%20multi-site%20case-finding%20study.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosetta%22%2C%22lastName%22%3A%22Mazzola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20D.%22%2C%22lastName%22%3A%22Aaron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20L.%22%2C%22lastName%22%3A%22Vandemheen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunita%22%2C%22lastName%22%3A%22Mulpuru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Celine%22%2C%22lastName%22%3A%22Bergeron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Lemi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22C%5Cu00f4t%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis-Philippe%22%2C%22lastName%22%3A%22Boulet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20K.%22%2C%22lastName%22%3A%22Field%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Penz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Andrew%22%2C%22lastName%22%3A%22McIvor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samir%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irvin%22%2C%22lastName%22%3A%22Mayers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohit%22%2C%22lastName%22%3A%22Bhutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Hernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Diane%22%2C%22lastName%22%3A%22Lougheed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%22%2C%22lastName%22%3A%22Licskai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanweer%22%2C%22lastName%22%3A%22Azher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Ezer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martha%22%2C%22lastName%22%3A%22Ainslie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tetyana%22%2C%22lastName%22%3A%22Kendzerska%22%7D%5D%2C%22abstractNote%22%3A%22Obstructive%20airway%20disease%20is%20associated%20with%20sleep%20disturbances.%20We%20aimed%20to%20assess%20the%20relationship%20between%20lung%20function%20and%20sleep%20disorder%20symptoms%20using%20%20cross-sectionally%20collected%20data%20between%20March%202017%20and%20August%202021%20from%20the%20%20Undiagnosed%20Chronic%20Obstructive%20Pulmonary%20Disease%20and%20Asthma%20Population%20study%2C%20a%20%20prospective%20community-based%20multi-site%20case-finding%20study.%20Undiagnosed%20Chronic%20%20Obstructive%20Pulmonary%20Disease%20and%20Asthma%20Population%20study%20participants%20with%20%20respiratory%20symptoms%20but%20without%20diagnosed%20lung%20disease%20who%20completed%20spirometry%20%20and%20the%20Global%20Sleep%20Assessment%20Questionnaire%20were%20included.%20We%20conducted%20%20multivariate%20linear%20regression%20models%20for%20forced%20expiratory%20volume%20in%201%5Cu2005s%2C%20forced%20%20vital%20capacity%20and%20forced%20expiratory%20volume%20in%201%5Cu2005s%5C%2Fforced%20vital%20capacity%20by%20%20Global%20Sleep%20Assessment%20Questionnaire%20responses%20adjusted%20for%20confounders.%20The%20%20same%20models%20were%20employed%20to%20examine%20respiratory%20symptoms%2C%20as%20reported%20on%20the%20St%20%20George%26%23039%3Bs%20Respiratory%20Questionnaire%20and%20Chronic%20Obstructive%20Pulmonary%20Disease%20%20Assessment%20Test%2C%20by%20Global%20Sleep%20Assessment%20Questionnaire%20responses.%20Logistic%20%20regression%20models%20were%20used%20to%20assess%20the%20association%20of%20undiagnosed%20obstructive%20%20airway%20disease%20with%20sleep%20symptoms.%20Amongst%202093%20adults%20included%20in%20the%20study%2C%20%2048.3%25%20were%20female%20and%20the%20median%20age%20was%2063%5Cu2009years%20%28interquartile%20range%2053-72%29.%20%20Two-hundred%20and%20five%20%289.79%25%29%20subjects%20met%20spirometry%20criteria%20for%20undiagnosed%20%20chronic%20obstructive%20pulmonary%20disease%2C%20and%20191%20%289.13%25%29%20for%20undiagnosed%20asthma.%20%20There%20were%20no%20significant%20associations%20between%20spirometry%20measures%20and%20sleep%20%20symptoms%20%28p%5Cu2009%26gt%3B%5Cu20090.5%29%2C%20controlling%20for%20age%2C%20sex%2C%20body%20mass%20index%2C%20smoking%20and%20%20comorbidities.%20Those%20with%20undiagnosed%20asthma%20were%20more%20likely%20to%20report%20insomnia%20%20%26quot%3Bat%20least%20sometimes%26quot%3B%20versus%20%26quot%3Bnever%26quot%3B%20%28odds%20ratio%202.58%2C%2095%25%20confidence%20interval%3A%20%201.27-6.19%2C%20p%5Cu2009%3D%5Cu20090.02%29.%20Respiratory%20symptoms%20were%20associated%20with%20sleep%20symptoms%2C%20%20with%20significant%20%28p%5Cu2009%26lt%3B%5Cu20090.05%29%20increases%20in%20St%20George%26%23039%3Bs%20Respiratory%20Questionnaire%20%20and%20Chronic%20Obstructive%20Pulmonary%20Disease%20Assessment%20Test%20scores%20in%20those%20%20reporting%20most%20sleep%20symptoms.%20Overall%2C%20we%20found%20an%20association%20between%20%20undiagnosed%20asthma%20and%20insomnia%2C%20and%20between%20respiratory%20and%20sleep%20disorder%20%20symptoms.%22%2C%22date%22%3A%222025%20Jun%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fjsr.14356%22%2C%22ISSN%22%3A%221365-2869%200962-1105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222DMQQWZ2%22%5D%2C%22dateModified%22%3A%222025-05-23T13%3A36%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22DR7GSI2K%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lugogo%20et%20al.%22%2C%22parsedDate%22%3A%222025-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLugogo%2C%20Njira%20L.%2C%20Xavier%20Soler%2C%20Yasuhiro%20Gon%2C%20et%20al.%202025.%20%26%23x201C%3BBaseline%20Characteristics%20of%20Dupilumab-Treated%20Patients%20with%20Asthma%20in%20the%20Real%20World%3A%20The%20RAPID%20Global%20Registry.%26%23x201D%3B%20%26lt%3Bi%26gt%3BAdvances%20in%20Therapy%26lt%3B%5C%2Fi%26gt%3B%2042%20%282%29%3A%20849%26%23x2013%3B62.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12325-024-03051-0%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12325-024-03051-0%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Baseline%20Characteristics%20of%20Dupilumab-Treated%20Patients%20with%20Asthma%20in%20the%20Real%20World%3A%20The%20RAPID%20Global%20Registry.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Njira%20L.%22%2C%22lastName%22%3A%22Lugogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Soler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yasuhiro%22%2C%22lastName%22%3A%22Gon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22C%5Cu00f4t%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ole%22%2C%22lastName%22%3A%22Hilberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changming%22%2C%22lastName%22%3A%22Xia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luc%5Cu00eda%22%2C%22lastName%22%3A%22de%20Prado%20G%5Cu00f3mez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20J.%22%2C%22lastName%22%3A%22Rowe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amr%22%2C%22lastName%22%3A%22Radwan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juby%20A.%22%2C%22lastName%22%3A%22Jacob-Nara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yamo%22%2C%22lastName%22%3A%22Deniz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%20T.%22%2C%22lastName%22%3A%22Peters%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Patients%20with%20uncontrolled%2C%20moderate-to-severe%20asthma%20have%20a%20higher%20risk%20for%20exacerbations%2C%20negatively%20impacting%20lung%20function%20and%20quality%20of%20life.%20%20Dupilumab%2C%20a%20fully%20human%20monoclonal%20antibody%2C%20blocks%20interleukins%204%20and%2013%2C%20key%20%20and%20central%20drivers%20of%20type%202%20inflammation.%20Dupilumab%20has%20been%20effective%20in%20the%20%20treatment%20of%20certain%20types%20of%20moderate-to-severe%20asthma%20across%20several%20clinical%20%20trials.%20We%20describe%20the%20characteristics%20of%20patients%20enrolled%20in%20RAPID%2C%20a%20global%20%20prospective%20registry%2C%20who%20initiated%20dupilumab%20%28primary%20indication%3A%20asthma%29%20in%20a%20%20real-world%20clinical%20setting.%20METHODS%3A%20A%20total%20of%20205%20patients%20%28aged%5Cu00a0%5Cu2265%5Cu00a012%5Cu00a0years%29%20%20were%20enrolled%20between%20March%202020%20and%20October%202021%20and%20are%20included%20in%20this%20%20analysis.%20Data%20are%20shown%20as%20mean%20%28SD%29%20unless%20stated%20otherwise.%20RESULTS%3A%20Patients%20%20were%20aged%2050.1%20%2817.4%29%20years%20and%20were%20mostly%20female%20%2865.4%25%29%20and%20white%20%2874.1%25%29.%20At%20%20enrollment%2C%2024.4%25%20reported%20being%20current%5C%2Fformer%20smokers%20and%2086.8%25%20had%20%20moderate-to-severe%20asthma%20%28Global%20Initiative%20for%20Asthma%20steps%203-5%29.%20A%20mean%20%28SD%29%20%20of%204.4%20%286.4%29%20severe%20asthma%20exacerbations%20were%20reported%20in%20the%20year%20before%20%20enrolling%20in%20the%20registry%20in%2078%20of%20152%20patients%20with%20available%20data.%20Patients%20had%20%20reduced%20lung%20function%20%5Bpre-bronchodilator%20forced%20expiratory%20volume%20in%201%5Cu00a0s%20%20%28FEV%281%29%29%3A%202.3%20%281.1%29%20L%3B%20pre-bronchodilator%20percent%20predicted%20FEV%281%29%3A%2070.3%20%2820.3%29%20%20%25%5D%20and%20poor%20asthma%20control%20%5B6-item%20Asthma%20Control%20Questionnaire%3A%202.4%20%281.2%29%3B%20%20Asthma%20Quality%20of%20Life%20Questionnaire%3A%204.1%20%281.3%29%5D.%20The%20median%20%28Q1-Q3%29%20blood%20%20eosinophil%20count%20was%20305%20%28200-695%29%20cells%5C%2F%5Cu00b5L%20and%20the%20mean%20%28SD%29%20fractional%20exhaled%20%20nitric%20oxide%20levels%20were%2042%20%2835%29%20ppb%20%28range%3A%204-186%5Cu00a0ppb%29.%20CONCLUSION%3A%20Our%20findings%20%20suggest%20that%20most%20patients%20who%20enrolled%20in%20RAPID%20and%20initiated%20dupilumab%20in%20%20real-world%20clinical%20settings%20had%20a%20high%20disease%20burden%2C%20despite%20receiving%20current%20%20standard-of-care%20treatment%20at%20enrollment.%22%2C%22date%22%3A%222025%20Feb%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12325-024-03051-0%22%2C%22ISSN%22%3A%221865-8652%200741-238X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%227WZ3HMHG%22%5D%2C%22dateModified%22%3A%222025-04-08T16%3A50%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22UQTCYMEH%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lugogo%20et%20al.%22%2C%22parsedDate%22%3A%222025-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLugogo%2C%20Njira%20L.%2C%20Xavier%20Soler%2C%20Yasuhiro%20Gon%2C%20et%20al.%202025.%20%26%23x201C%3BBaseline%20Characteristics%20of%20Dupilumab-Treated%20Patients%20with%20Asthma%20in%20the%20Real%20World%3A%20The%20RAPID%20Global%20Registry.%26%23x201D%3B%20%26lt%3Bi%26gt%3BAdvances%20in%20Therapy%26lt%3B%5C%2Fi%26gt%3B%2042%20%282%29%3A%20849%26%23x2013%3B62.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12325-024-03051-0%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12325-024-03051-0%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Baseline%20Characteristics%20of%20Dupilumab-Treated%20Patients%20with%20Asthma%20in%20the%20Real%20World%3A%20The%20RAPID%20Global%20Registry.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Njira%20L.%22%2C%22lastName%22%3A%22Lugogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Soler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yasuhiro%22%2C%22lastName%22%3A%22Gon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22C%5Cu00f4t%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ole%22%2C%22lastName%22%3A%22Hilberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changming%22%2C%22lastName%22%3A%22Xia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luc%5Cu00eda%22%2C%22lastName%22%3A%22de%20Prado%20G%5Cu00f3mez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20J.%22%2C%22lastName%22%3A%22Rowe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amr%22%2C%22lastName%22%3A%22Radwan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juby%20A.%22%2C%22lastName%22%3A%22Jacob-Nara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yamo%22%2C%22lastName%22%3A%22Deniz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%20T.%22%2C%22lastName%22%3A%22Peters%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Patients%20with%20uncontrolled%2C%20moderate-to-severe%20asthma%20have%20a%20higher%20risk%20for%20exacerbations%2C%20negatively%20impacting%20lung%20function%20and%20quality%20of%20life.%20%20Dupilumab%2C%20a%20fully%20human%20monoclonal%20antibody%2C%20blocks%20interleukins%204%20and%2013%2C%20key%20%20and%20central%20drivers%20of%20type%202%20inflammation.%20Dupilumab%20has%20been%20effective%20in%20the%20%20treatment%20of%20certain%20types%20of%20moderate-to-severe%20asthma%20across%20several%20clinical%20%20trials.%20We%20describe%20the%20characteristics%20of%20patients%20enrolled%20in%20RAPID%2C%20a%20global%20%20prospective%20registry%2C%20who%20initiated%20dupilumab%20%28primary%20indication%3A%20asthma%29%20in%20a%20%20real-world%20clinical%20setting.%20METHODS%3A%20A%20total%20of%20205%20patients%20%28aged%5Cu00a0%5Cu2265%5Cu00a012%5Cu00a0years%29%20%20were%20enrolled%20between%20March%202020%20and%20October%202021%20and%20are%20included%20in%20this%20%20analysis.%20Data%20are%20shown%20as%20mean%20%28SD%29%20unless%20stated%20otherwise.%20RESULTS%3A%20Patients%20%20were%20aged%2050.1%20%2817.4%29%20years%20and%20were%20mostly%20female%20%2865.4%25%29%20and%20white%20%2874.1%25%29.%20At%20%20enrollment%2C%2024.4%25%20reported%20being%20current%5C%2Fformer%20smokers%20and%2086.8%25%20had%20%20moderate-to-severe%20asthma%20%28Global%20Initiative%20for%20Asthma%20steps%203-5%29.%20A%20mean%20%28SD%29%20%20of%204.4%20%286.4%29%20severe%20asthma%20exacerbations%20were%20reported%20in%20the%20year%20before%20%20enrolling%20in%20the%20registry%20in%2078%20of%20152%20patients%20with%20available%20data.%20Patients%20had%20%20reduced%20lung%20function%20%5Bpre-bronchodilator%20forced%20expiratory%20volume%20in%201%5Cu00a0s%20%20%28FEV%281%29%29%3A%202.3%20%281.1%29%20L%3B%20pre-bronchodilator%20percent%20predicted%20FEV%281%29%3A%2070.3%20%2820.3%29%20%20%25%5D%20and%20poor%20asthma%20control%20%5B6-item%20Asthma%20Control%20Questionnaire%3A%202.4%20%281.2%29%3B%20%20Asthma%20Quality%20of%20Life%20Questionnaire%3A%204.1%20%281.3%29%5D.%20The%20median%20%28Q1-Q3%29%20blood%20%20eosinophil%20count%20was%20305%20%28200-695%29%20cells%5C%2F%5Cu00b5L%20and%20the%20mean%20%28SD%29%20fractional%20exhaled%20%20nitric%20oxide%20levels%20were%2042%20%2835%29%20ppb%20%28range%3A%204-186%5Cu00a0ppb%29.%20CONCLUSION%3A%20Our%20findings%20%20suggest%20that%20most%20patients%20who%20enrolled%20in%20RAPID%20and%20initiated%20dupilumab%20in%20%20real-world%20clinical%20settings%20had%20a%20high%20disease%20burden%2C%20despite%20receiving%20current%20%20standard-of-care%20treatment%20at%20enrollment.%22%2C%22date%22%3A%222025%20Feb%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12325-024-03051-0%22%2C%22ISSN%22%3A%221865-8652%200741-238X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22K2A9NM7M%22%5D%2C%22dateModified%22%3A%222025-04-08T14%3A21%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22N9SFHSKW%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22C%5Cu00f4t%5Cu00e9%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BC%26%23xF4%3Bt%26%23xE9%3B%2C%20Andr%26%23xE9%3Banne%2C%20Rosalie%20Beaul%26%23xE9%3B%2C%20Marie-%26%23xC8%3Bve%20Boulay%2C%20et%20al.%202025.%20%26%23x201C%3BPoor%20Agreement%20Among%20Asthma%20Specialists%20on%20the%20Choice%20and%20Timing%20of%20Initiation%20of%20a%20Biologic%20Treatment%20for%20Severe%20Asthma%20Patients.%26%23x201D%3B%20%26lt%3Bi%26gt%3BThe%20Journal%20of%20Allergy%20and%20Clinical%20Immunology.%20In%20Practice%26lt%3B%5C%2Fi%26gt%3B%2C%20January%2024%2C%20S2213-2198%2825%2900061-3.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaip.2025.01.017%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaip.2025.01.017%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Poor%20Agreement%20Among%20Asthma%20Specialists%20on%20the%20Choice%20and%20Timing%20of%20Initiation%20of%20a%20Biologic%20Treatment%20for%20Severe%20Asthma%20Patients.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22C%5Cu00f4t%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosalie%22%2C%22lastName%22%3A%22Beaul%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-%5Cu00c8ve%22%2C%22lastName%22%3A%22Boulay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakie%22%2C%22lastName%22%3A%22Guertin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis-Philippe%22%2C%22lastName%22%3A%22Boulet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krystelle%22%2C%22lastName%22%3A%22Godbout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Price%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Because%20the%20number%20of%20monoclonal%20antibodies%20available%20for%20severe%20asthma%20is%20growing%2C%20specialists%20currently%20choose%20without%20clear%20guidelines.%20Despite%20%20increasing%20knowledge%20on%20treatment%20response%20to%20these%20monoclonal%20antibodies%2C%20making%20%20the%20optimal%20choice%20for%20each%20individual%20patient%20remains%20a%20challenge.%20However%2C%20%20evidence%20of%20this%20daily%20challenge%20is%20lacking.%20OBJECTIVE%3A%20To%20evaluate%20interobserver%20%20agreement%20on%20the%20choice%20of%20biologic%20therapy%20in%20severe%20asthma%20patients%20among%20%20severe%20asthma%20specialists%2C%20based%20on%20clinical%20cases.%20METHODS%3A%20This%202-phase%20study%20%20included%20a%20pilot%20local%20study%20and%20an%20international%20validation%20study.%20Asthma%20%20specialists%20were%20presented%207%20real-life%20asthma%20cases%20managed%20with%20a%20monoclonal%20%20antibody.%20Based%20on%20the%20clinical%20information%20provided%20in%20the%20cases%2C%20they%20were%20%20asked%20whether%20they%20would%20have%20initiated%20a%20monoclonal%20antibody%20and%2C%20if%20so%2C%20their%20%20treatment%20of%20choice%20between%20%281%29%20omalizumab%2C%20%282%29%20mepolizumab%2C%20%283%29%20reslizumab%2C%20%284%29%20%20benralizumab%2C%20and%20%285%29%20dupilumab.%20Interobserver%20agreement%20for%20each%20question%20was%20%20assessed%20using%20Gwet%20agreement%20coefficient%20%28AC1%29.%20RESULTS%3A%20Sixteen%20physicians%20from%20%20the%20Province%20of%20Quebec%20%28Canada%29%20completed%20the%20pilot%20survey%2C%20and%2070%20physicians%20%20from%2026%20countries%20completed%20the%20international%20survey.%20The%20Gwet%20AC1%20for%20the%20%20decision%20to%20initiate%20a%20biological%20therapy%20was%200.48%20in%20the%20pilot%20survey%20and%200.33%20%20in%20the%20international%20survey.%20For%20the%20choice%20of%20therapy%2C%20agreement%20was%200.33%20and%20%200.26%2C%20respectively.%20CONCLUSIONS%3A%20The%20interobserver%20agreement%20among%20asthma%20%20specialists%20in%20both%20the%20decision%20to%20initiate%20a%20biological%20treatment%20in%20patients%20%20with%20severe%20asthma%20and%20the%20selection%20of%20treatment%20is%20weak.%20These%20results%20%20highlight%20the%20need%20for%20studies%20seeking%20reliable%20predictors%20for%20optimal%20response%20%20to%20biological%20therapies.%22%2C%22date%22%3A%222025%20Jan%2024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jaip.2025.01.017%22%2C%22ISSN%22%3A%222213-2201%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%227WZ3HMHG%22%5D%2C%22dateModified%22%3A%222025-04-08T16%3A50%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22FZ5T5ZGL%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22C%5Cu00f4t%5Cu00e9%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BC%26%23xF4%3Bt%26%23xE9%3B%2C%20Andr%26%23xE9%3Banne%2C%20Rosalie%20Beaul%26%23xE9%3B%2C%20Marie-%26%23xC8%3Bve%20Boulay%2C%20et%20al.%202025.%20%26%23x201C%3BPoor%20Agreement%20Among%20Asthma%20Specialists%20on%20the%20Choice%20and%20Timing%20of%20Initiation%20of%20a%20Biologic%20Treatment%20for%20Severe%20Asthma%20Patients.%26%23x201D%3B%20%26lt%3Bi%26gt%3BThe%20Journal%20of%20Allergy%20and%20Clinical%20Immunology.%20In%20Practice%26lt%3B%5C%2Fi%26gt%3B%2C%20January%2024%2C%20S2213-2198%2825%2900061-3.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaip.2025.01.017%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jaip.2025.01.017%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Poor%20Agreement%20Among%20Asthma%20Specialists%20on%20the%20Choice%20and%20Timing%20of%20Initiation%20of%20a%20Biologic%20Treatment%20for%20Severe%20Asthma%20Patients.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22C%5Cu00f4t%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosalie%22%2C%22lastName%22%3A%22Beaul%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-%5Cu00c8ve%22%2C%22lastName%22%3A%22Boulay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakie%22%2C%22lastName%22%3A%22Guertin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis-Philippe%22%2C%22lastName%22%3A%22Boulet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krystelle%22%2C%22lastName%22%3A%22Godbout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Price%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Because%20the%20number%20of%20monoclonal%20antibodies%20available%20for%20severe%20asthma%20is%20growing%2C%20specialists%20currently%20choose%20without%20clear%20guidelines.%20Despite%20%20increasing%20knowledge%20on%20treatment%20response%20to%20these%20monoclonal%20antibodies%2C%20making%20%20the%20optimal%20choice%20for%20each%20individual%20patient%20remains%20a%20challenge.%20However%2C%20%20evidence%20of%20this%20daily%20challenge%20is%20lacking.%20OBJECTIVE%3A%20To%20evaluate%20interobserver%20%20agreement%20on%20the%20choice%20of%20biologic%20therapy%20in%20severe%20asthma%20patients%20among%20%20severe%20asthma%20specialists%2C%20based%20on%20clinical%20cases.%20METHODS%3A%20This%202-phase%20study%20%20included%20a%20pilot%20local%20study%20and%20an%20international%20validation%20study.%20Asthma%20%20specialists%20were%20presented%207%20real-life%20asthma%20cases%20managed%20with%20a%20monoclonal%20%20antibody.%20Based%20on%20the%20clinical%20information%20provided%20in%20the%20cases%2C%20they%20were%20%20asked%20whether%20they%20would%20have%20initiated%20a%20monoclonal%20antibody%20and%2C%20if%20so%2C%20their%20%20treatment%20of%20choice%20between%20%281%29%20omalizumab%2C%20%282%29%20mepolizumab%2C%20%283%29%20reslizumab%2C%20%284%29%20%20benralizumab%2C%20and%20%285%29%20dupilumab.%20Interobserver%20agreement%20for%20each%20question%20was%20%20assessed%20using%20Gwet%20agreement%20coefficient%20%28AC1%29.%20RESULTS%3A%20Sixteen%20physicians%20from%20%20the%20Province%20of%20Quebec%20%28Canada%29%20completed%20the%20pilot%20survey%2C%20and%2070%20physicians%20%20from%2026%20countries%20completed%20the%20international%20survey.%20The%20Gwet%20AC1%20for%20the%20%20decision%20to%20initiate%20a%20biological%20therapy%20was%200.48%20in%20the%20pilot%20survey%20and%200.33%20%20in%20the%20international%20survey.%20For%20the%20choice%20of%20therapy%2C%20agreement%20was%200.33%20and%20%200.26%2C%20respectively.%20CONCLUSIONS%3A%20The%20interobserver%20agreement%20among%20asthma%20%20specialists%20in%20both%20the%20decision%20to%20initiate%20a%20biological%20treatment%20in%20patients%20%20with%20severe%20asthma%20and%20the%20selection%20of%20treatment%20is%20weak.%20These%20results%20%20highlight%20the%20need%20for%20studies%20seeking%20reliable%20predictors%20for%20optimal%20response%20%20to%20biological%20therapies.%22%2C%22date%22%3A%222025%20Jan%2024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jaip.2025.01.017%22%2C%22ISSN%22%3A%222213-2201%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22K2A9NM7M%22%5D%2C%22dateModified%22%3A%222025-04-08T14%3A21%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22UMCKCNSE%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mazzola%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMazzola%2C%20Rosetta%2C%20Shawn%20D.%20Aaron%2C%20Katherine%20L.%20Vandemheen%2C%20et%20al.%202025.%20%26%23x201C%3BAssociation%20between%20Lung%20Function%20and%20Sleep%20Disorder%20Symptoms%20in%20a%20Community-Based%20Multi-Site%20Case-Finding%20Study.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Sleep%20Research%26lt%3B%5C%2Fi%26gt%3B%2034%20%283%29%3A%20e14356.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjsr.14356%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjsr.14356%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20between%20lung%20function%20and%20sleep%20disorder%20symptoms%20in%20a%20community-based%20multi-site%20case-finding%20study.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosetta%22%2C%22lastName%22%3A%22Mazzola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20D.%22%2C%22lastName%22%3A%22Aaron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20L.%22%2C%22lastName%22%3A%22Vandemheen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunita%22%2C%22lastName%22%3A%22Mulpuru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Celine%22%2C%22lastName%22%3A%22Bergeron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Lemi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22C%5Cu00f4t%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis-Philippe%22%2C%22lastName%22%3A%22Boulet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20K.%22%2C%22lastName%22%3A%22Field%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Penz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Andrew%22%2C%22lastName%22%3A%22McIvor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samir%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irvin%22%2C%22lastName%22%3A%22Mayers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohit%22%2C%22lastName%22%3A%22Bhutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Hernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Diane%22%2C%22lastName%22%3A%22Lougheed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%22%2C%22lastName%22%3A%22Licskai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanweer%22%2C%22lastName%22%3A%22Azher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Ezer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martha%22%2C%22lastName%22%3A%22Ainslie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tetyana%22%2C%22lastName%22%3A%22Kendzerska%22%7D%5D%2C%22abstractNote%22%3A%22Obstructive%20airway%20disease%20is%20associated%20with%20sleep%20disturbances.%20We%20aimed%20to%20assess%20the%20relationship%20between%20lung%20function%20and%20sleep%20disorder%20symptoms%20using%20cross-sectionally%20collected%20data%20between%20March%202017%20and%20August%202021%20from%20the%20Undiagnosed%20Chronic%20Obstructive%20Pulmonary%20Disease%20and%20Asthma%20Population%20study%2C%20a%20prospective%20community-based%20multi-site%20case-finding%20study.%20Undiagnosed%20Chronic%20Obstructive%20Pulmonary%20Disease%20and%20Asthma%20Population%20study%20participants%20with%20respiratory%20symptoms%20but%20without%20diagnosed%20lung%20disease%20who%20completed%20spirometry%20and%20the%20Global%20Sleep%20Assessment%20Questionnaire%20were%20included.%20We%20conducted%20multivariate%20linear%20regression%20models%20for%20forced%20expiratory%20volume%20in%201%20s%2C%20forced%20vital%20capacity%20and%20forced%20expiratory%20volume%20in%201%20s%5C%2Fforced%20vital%20capacity%20by%20Global%20Sleep%20Assessment%20Questionnaire%20responses%20adjusted%20for%20confounders.%20The%20same%20models%20were%20employed%20to%20examine%20respiratory%20symptoms%2C%20as%20reported%20on%20the%20St%20George%26%23039%3Bs%20Respiratory%20Questionnaire%20and%20Chronic%20Obstructive%20Pulmonary%20Disease%20Assessment%20Test%2C%20by%20Global%20Sleep%20Assessment%20Questionnaire%20responses.%20Logistic%20regression%20models%20were%20used%20to%20assess%20the%20association%20of%20undiagnosed%20obstructive%20airway%20disease%20with%20sleep%20symptoms.%20Amongst%202093%20adults%20included%20in%20the%20study%2C%2048.3%25%20were%20female%20and%20the%20median%20age%20was%2063%20years%20%28interquartile%20range%2053-72%29.%20Two-hundred%20and%20five%20%289.79%25%29%20subjects%20met%20spirometry%20criteria%20for%20undiagnosed%20chronic%20obstructive%20pulmonary%20disease%2C%20and%20191%20%289.13%25%29%20for%20undiagnosed%20asthma.%20There%20were%20no%20significant%20associations%20between%20spirometry%20measures%20and%20sleep%20symptoms%20%28p%20%26gt%3B%200.5%29%2C%20controlling%20for%20age%2C%20sex%2C%20body%20mass%20index%2C%20smoking%20and%20comorbidities.%20Those%20with%20undiagnosed%20asthma%20were%20more%20likely%20to%20report%20insomnia%20%26quot%3Bat%20least%20sometimes%26quot%3B%20versus%20%26quot%3Bnever%26quot%3B%20%28odds%20ratio%202.58%2C%2095%25%20confidence%20interval%3A%201.27-6.19%2C%20p%20%3D%200.02%29.%20Respiratory%20symptoms%20were%20associated%20with%20sleep%20symptoms%2C%20with%20significant%20%28p%20%26lt%3B%200.05%29%20increases%20in%20St%20George%26%23039%3Bs%20Respiratory%20Questionnaire%20and%20Chronic%20Obstructive%20Pulmonary%20Disease%20Assessment%20Test%20scores%20in%20those%20reporting%20most%20sleep%20symptoms.%20Overall%2C%20we%20found%20an%20association%20between%20undiagnosed%20asthma%20and%20insomnia%2C%20and%20between%20respiratory%20and%20sleep%20disorder%20symptoms.%22%2C%22date%22%3A%222025%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1111%5C%2Fjsr.14356%22%2C%22ISSN%22%3A%221365-2869%200962-1105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22D7MLPNTI%22%5D%2C%22dateModified%22%3A%222025-05-23T14%3A17%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22SQENKHDJ%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lugogo%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLugogo%2C%20Njira%20L.%2C%20Xavier%20Soler%2C%20Yasuhiro%20Gon%2C%20et%20al.%202025.%20%26%23x201C%3BBaseline%20Characteristics%20of%20Dupilumab-Treated%20Patients%20with%20Asthma%20in%20the%20Real%20World%3A%20The%20RAPID%20Global%20Registry.%26%23x201D%3B%20%26lt%3Bi%26gt%3BAdvances%20in%20Therapy%26lt%3B%5C%2Fi%26gt%3B%2042%20%282%29%3A%20849%26%23x2013%3B62.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12325-024-03051-0%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12325-024-03051-0%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Baseline%20Characteristics%20of%20Dupilumab-Treated%20Patients%20with%20Asthma%20in%20the%20Real%20World%3A%20The%20RAPID%20Global%20Registry.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Njira%20L.%22%2C%22lastName%22%3A%22Lugogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Soler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yasuhiro%22%2C%22lastName%22%3A%22Gon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22C%5Cu00f4t%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ole%22%2C%22lastName%22%3A%22Hilberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changming%22%2C%22lastName%22%3A%22Xia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luc%5Cu00eda%22%2C%22lastName%22%3A%22de%20Prado%20G%5Cu00f3mez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20J.%22%2C%22lastName%22%3A%22Rowe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amr%22%2C%22lastName%22%3A%22Radwan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juby%20A.%22%2C%22lastName%22%3A%22Jacob-Nara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yamo%22%2C%22lastName%22%3A%22Deniz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%20T.%22%2C%22lastName%22%3A%22Peters%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%3A%20Patients%20with%20uncontrolled%2C%20moderate-to-severe%20asthma%20have%20a%20higher%20risk%20for%20exacerbations%2C%20negatively%20impacting%20lung%20function%20and%20quality%20of%20life.%20Dupilumab%2C%20a%20fully%20human%20monoclonal%20antibody%2C%20blocks%20interleukins%204%20and%2013%2C%20key%20and%20central%20drivers%20of%20type%202%20inflammation.%20Dupilumab%20has%20been%20effective%20in%20the%20treatment%20of%20certain%20types%20of%20moderate-to-severe%20asthma%20across%20several%20clinical%20trials.%20We%20describe%20the%20characteristics%20of%20patients%20enrolled%20in%20RAPID%2C%20a%20global%20prospective%20registry%2C%20who%20initiated%20dupilumab%20%28primary%20indication%3A%20asthma%29%20in%20a%20real-world%20clinical%20setting.%20Methods%3A%20A%20total%20of%20205%20patients%20%28aged%5Cu00a0%5Cu2265%5Cu00a012%5Cu00a0years%29%20were%20enrolled%20between%20March%202020%20and%20October%202021%20and%20are%20included%20in%20this%20analysis.%20Data%20are%20shown%20as%20mean%20%28SD%29%20unless%20stated%20otherwise.%20Results%3A%20Patients%20%20were%20aged%2050.1%20%2817.4%29%20years%20and%20were%20mostly%20female%20%2865.4%25%29%20and%20white%20%2874.1%25%29.%20At%20%20enrollment%2C%2024.4%25%20reported%20being%20current%5C%2Fformer%20smokers%20and%2086.8%25%20had%20moderate-to-severe%20asthma%20%28Global%20Initiative%20for%20Asthma%20steps%203%5Cu20135%29.%20A%20mean%20%28SD%29%20of%204.4%20%286.4%29%20severe%20asthma%20exacerbations%20were%20reported%20in%20the%20year%20before%20enrolling%20in%20the%20registry%20in%2078%20of%20152%20patients%20with%20available%20data.%20Patients%20had%20reduced%20lung%20function%20%5Bpre-bronchodilator%20forced%20expiratory%20volume%20in%201%5Cu00a0s%20%28FEV1%29%3A%202.3%20%281.1%29%20L%3B%20pre-bronchodilator%20percent%20predicted%20FEV1%3A%2070.3%20%2820.3%29%20%25%5D%20and%20poor%20asthma%20control%20%5B6-item%20Asthma%20Control%20Questionnaire%3A%202.4%20%281.2%29%3B%20Asthma%20Quality%20of%20Life%20Questionnaire%3A%204.1%20%281.3%29%5D.%20The%20median%20%28Q1%5Cu2013Q3%29%20blood%20eosinophil%20count%20was%20305%20%28200%5Cu2013695%29%20cells%5C%2F%5Cu00b5L%20and%20the%20mean%20%28SD%29%20fractional%20exhaled%20nitric%20oxide%20levels%20were%20%2042%20%2835%29%20ppb%20%28range%3A%204%5Cu2013186%5Cu00a0ppb%29.%20Conclusion%3A%20Our%20findings%20suggest%20that%20most%20patients%20who%20enrolled%20in%20RAPID%20and%20initiated%20dupilumab%20in%20real-world%20clinical%20settings%20had%20a%20high%20disease%20burden%2C%20despite%20receiving%20current%20standard-of-care%20treatment%20at%20enrollment.%20Supplementary%20Information%3A%20The%20online%20version%20contains%20supplementary%20material%20available%20at%2010.1007%5C%2Fs12325-024-03051-0.%22%2C%22date%22%3A%222025%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12325-024-03051-0%22%2C%22ISSN%22%3A%220741-238X%201865-8652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22IQBCKQ5T%22%5D%2C%22dateModified%22%3A%222025-04-09T17%3A55%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22KSD4MDTX%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lugogo%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLugogo%2C%20Njira%20L.%2C%20Xavier%20Soler%2C%20Yasuhiro%20Gon%2C%20et%20al.%202025.%20%26%23x201C%3BBaseline%20Characteristics%20of%20Dupilumab-Treated%20Patients%20with%20Asthma%20in%20the%20Real%20World%3A%20The%20RAPID%20Global%20Registry.%26%23x201D%3B%20%26lt%3Bi%26gt%3BAdvances%20in%20Therapy%26lt%3B%5C%2Fi%26gt%3B%2042%20%282%29%3A%20849%26%23x2013%3B62.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12325-024-03051-0%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12325-024-03051-0%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Baseline%20Characteristics%20of%20Dupilumab-Treated%20Patients%20with%20Asthma%20in%20the%20Real%20World%3A%20The%20RAPID%20Global%20Registry.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Njira%20L.%22%2C%22lastName%22%3A%22Lugogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Soler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yasuhiro%22%2C%22lastName%22%3A%22Gon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22C%5Cu00f4t%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ole%22%2C%22lastName%22%3A%22Hilberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changming%22%2C%22lastName%22%3A%22Xia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luc%5Cu00eda%22%2C%22lastName%22%3A%22de%20Prado%20G%5Cu00f3mez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20J.%22%2C%22lastName%22%3A%22Rowe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amr%22%2C%22lastName%22%3A%22Radwan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juby%20A.%22%2C%22lastName%22%3A%22Jacob-Nara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yamo%22%2C%22lastName%22%3A%22Deniz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anju%20T.%22%2C%22lastName%22%3A%22Peters%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%3A%20Patients%20with%20uncontrolled%2C%20moderate-to-severe%20asthma%20have%20a%20higher%20risk%20for%20exacerbations%2C%20negatively%20impacting%20lung%20function%20and%20quality%20of%20life.%20Dupilumab%2C%20a%20fully%20human%20monoclonal%20antibody%2C%20blocks%20interleukins%204%20and%2013%2C%20key%20and%20central%20drivers%20of%20type%202%20inflammation.%20Dupilumab%20has%20been%20effective%20in%20the%20treatment%20of%20certain%20types%20of%20moderate-to-severe%20asthma%20across%20several%20clinical%20trials.%20We%20describe%20the%20characteristics%20of%20patients%20enrolled%20in%20RAPID%2C%20a%20global%20prospective%20registry%2C%20who%20initiated%20dupilumab%20%28primary%20indication%3A%20asthma%29%20in%20a%20real-world%20clinical%20setting.%20Methods%3A%20A%20total%20of%20205%20patients%20%28aged%20%5Cu2265%2012%20years%29%20were%20enrolled%20between%20March%202020%20and%20October%202021%20and%20are%20included%20in%20this%20analysis.%20Data%20are%20shown%20as%20mean%20%28SD%29%20unless%20stated%20otherwise.%20Results%3A%20Patients%20were%20aged%2050.1%20%2817.4%29%20years%20and%20were%20mostly%20female%20%2865.4%25%29%20and%20white%20%2874.1%25%29.%20At%20enrollment%2C%2024.4%25%20reported%20being%20current%5C%2Fformer%20smokers%20and%2086.8%25%20had%20moderate-to-severe%20asthma%20%28Global%20Initiative%20for%20Asthma%20steps%203%5Cu20135%29.%20A%20mean%20%28SD%29%20of%204.4%20%286.4%29%20severe%20asthma%20exacerbations%20were%20reported%20in%20the%20year%20before%20enrolling%20in%20the%20registry%20in%2078%20of%20152%20patients%20with%20available%20data.%20Patients%20had%20reduced%20lung%20function%20%5Bpre-bronchodilator%20forced%20expiratory%20volume%20in%201%20s%20%28FEV1%29%3A%202.3%20%281.1%29%20L%3B%20pre-bronchodilator%20percent%20predicted%20FEV1%3A%2070.3%20%2820.3%29%20%25%5D%20and%20poor%20asthma%20control%20%5B6-item%20Asthma%20Control%20Questionnaire%3A%202.4%20%281.2%29%3B%20Asthma%20Quality%20of%20Life%20Questionnaire%3A%204.1%20%281.3%29%5D.%20The%20median%20%28Q1%5Cu2013Q3%29%20blood%20eosinophil%20count%20was%20305%20%28200%5Cu2013695%29%20cells%5C%2F%5Cu00b5L%20and%20the%20mean%20%28SD%29%20fractional%20exhaled%20nitric%20oxide%20levels%20were%2042%20%2835%29%20ppb%20%28range%3A%204%5Cu2013186%20ppb%29.%20Conclusion%3A%20Our%20findings%20suggest%20that%20most%20patients%20who%20enrolled%20in%20RAPID%20and%20initiated%20dupilumab%20in%20real-world%20clinical%20settings%20had%20a%20high%20disease%20burden%2C%20despite%20receiving%20current%20standard-of-care%20treatment%20at%20enrollment.%20Supplementary%20Information%3A%20The%20online%20version%20contains%20supplementary%20material%20available%20at%2010.1007%5C%2Fs12325-024-03051-0.%22%2C%22date%22%3A%222025%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12325-024-03051-0%22%2C%22ISSN%22%3A%220741-238X%201865-8652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZQ8SN4L2%22%5D%2C%22dateModified%22%3A%222025-04-09T16%3A34%3A16Z%22%7D%7D%5D%7D

Mazzola, Rosetta, Shawn D. Aaron, Katherine L. Vandemheen, et al. 2025. “Association between Lung Function and Sleep Disorder Symptoms in a Community-Based Multi-Site Case-Finding Study.” Journal of Sleep Research 34 (3): e14356. https://doi.org/10.1111/jsr.14356.

Lugogo, Njira L., Xavier Soler, Yasuhiro Gon, et al. 2025. “Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry.” Advances in Therapy 42 (2): 849–62. https://doi.org/10.1007/s12325-024-03051-0.

Côté, Andréanne, Rosalie Beaulé, Marie-Ève Boulay, et al. 2025. “Poor Agreement Among Asthma Specialists on the Choice and Timing of Initiation of a Biologic Treatment for Severe Asthma Patients.” The Journal of Allergy and Clinical Immunology. In Practice, January 24, S2213-2198(25)00061-3. https://doi.org/10.1016/j.jaip.2025.01.017.

Soins palliatifs
Spiritualité
Souffrance
Approches complémentaires et alternatives
Art-based research method

Doctorat en médecine
Résidence en médecine de famille
Résidence dans le programme de compétences avancées en soins palliatifs
Maîtrise en sciences des religions
TUTOR PHC (Transdisciplinary understanding training on research in primary health care)

(En voie de publication) Côté A. Nguyen, O. « Chapitre : Les soins palliatifs adultes » dans Éthique clinique et situations complexes: un guide pratique. (Section Fin de vie, soins palliatifs et situations complexes). Antoine Payot, Marie-Ève Bouthillier, Julie Cousineau (dir.) Éditions Sainte-Justine.

(En cours de révision) Société québécoise des médecins de soins palliatifs et Collège des médecins du Québec (2015). La sédation palliative en fin de vie, guide d’exercice, Montréal, Collège des médecins du Québec, 2015, 61 p. Membre du comité de rédaction pour la Société québécoise des médecins de soins palliatifs.

Côté, A. (2018) « Laurence : trop peu, trop tard » Le Bulletin de l’Association québécoise de soins palliatifs. Automne 2018, vol 26, no 2, p. 39-41.

Côté A. La pratique du yoga thérapeutique en soins palliatifs. Entrevue dans la section En décalé de VigiPallia, Centre national sur la fin de vie et les soins palliatifs, France, publié en ligne en 2018/04.

Côté A, Jean N. (2018) « Intégrer les thérapies corps-esprit en soins palliatifs à domicile, rêve ou réalité? » Le Bulletin de l’Association québécoise de soins palliatifs. Hiver 2018, vol 26, no 1, p. 19-24.

Jean N, Côté A. (2018) « Interdisciplinarité et bénévolat en soins palliatifs à domicile : au-delà des concepts. » Le Bulletin de l’Association québécoise de soins palliatifs. Hiver 2018, vol 26, no 1, p. 12-18.

Ouellet P, Côté A, Carrier M-C. (2018) « Rapport de mi-projet Bourse AQSP 2016. Le Bulletin de l’Association québécoise de soins palliatifs. Hiver 2018, vol 26, no 1, p. 34.

Côté A (2016). « La question du sens ébranlée à l’ère de l’aide médicale à mourir », SpiritualitéSanté, 2016, Vol. 9, no 3, p. 22-25.

Daneault S, Lussier V, Mongeau S, Yelle L, Côté A, Sicotte C, Paillé P, Dion D, Coulombe, M (2016). « The ultimate journey of the terminally ill: between hope and despair », Can Fam Physician, 2016, Vol 62, p. 648-656.

Vinay P et collaborateurs. « Contrôler la douleur neuropathique : la méthadone en coanalgésie » Société québécoise des médecins de soins palliatifs. Accepté pour publication Médecine Palliative, Paris.

Azzaria S, Côté A, Dallaire M, Dechêne G, Gauvin F, La Fontaine L, Lapointe B, Martel C, Vinay P. (2015) « Recommandations québécoises pour la pratique de la sédation palliative : principes et pratique en médecine adulte » Société québécoise des Médecins de soins palliatifs. Médecine Palliative, Vol 14, no 6, p360-382.

Côté A, Cabagnols S, Abelé A (2015). « Yoga et soins palliatifs? Un programme de formation continue novateur », Le Bulletin du Réseau de soins palliatifs du Québec, automne 2015; 23(2) :20-21.

Côté A (2015). « Petit essai sur le sens ». Équilibre − Quel sens donner à la maladie ? La souffrance transforme le patient et le soignant, vol. 10, no 1, hiver 2015, p. 18-25.

Vinay P, Dallaire M, Côté A. (2014) « Fragilisation et construction identitaire en fin de vie » Cahiers francophones de soins palliatifs. Vol 14, no 2, p.51-58.

Côté A, Néron A (2014). « Les agents pharmacologiques impliqués dans la sédation palliative », Le Bulletin du Réseau de soins palliatifs du Québec, hiver 2014; 22(1) :8-12.

Côté A (2013). « Mise au point sur la sédation palliative », L’Actualité médicale, 2013; vol.34, no 16, p. 8.

Côté A (2013). « Le corps malade : à la recherche du sens », SpiritualitéSanté, 2013, Vol. 6, no 2, p. 10-13.

Côté A, Néron A, Vinay P, Laplante L, Gagnon L, De Médicis A (2013/02, accepté pour publication). « La sédation palliative à base de propofol : étude rétrospective », Médecine Palliative, 2013, Vol 12, No 6, p.272-278.

Côté, A (2013). « La philosophie du yoga et le processus d’acceptation de la mort », Cahiers francophones de soins palliatifs, 2013, Vol. 13, no 1, p.94-103.

Côté A, Daneault S (2012). « L’effet du yoga chez les patients atteints de cancer : bilan des connaissances actuelles ». Le médecin de famille canadien. 2012; 58 : 933-938.

Côté, A (2012). Compte-rendu critique de lecture « Souffrance spirituelle du patient en fin de vie : la question du sens de Bénédicte Échard », Frontières – L’aide médicale à mourir, 2011/2012, vol. 24, no 1 et 2, p.129-130.

Mémoire de maîtrise

Côté A. Grenier C. '' Laboratoire créatif sur la transition vers la fin de vie '' Congrès canadien de soins palliatifs, Ottawa, 21 septembre 2019

Jean, N. Côté, A. Bernard, S. Collard, N. Duru, J-M. « Regards croisés sur le mourir à domicile : du choix individuel au projet collectif » Conférence au Congrès de l’Association de soins palliatifs du Québec – 9 mai 2019

Levallois B. Copel L. Côté A. « Typologie des sédations palliatives » Classe de maître dans le cadre du Congrès de l’Association de soins palliatifs du Québec – 3 mai 2018

Côté A. « Intégration des méthodes de recherche basées sur l’art : genèse d’un projet » Présentation orale dans le cadre l’Assemblée annuelle du DMFMU – Université de Montréal, 11 mai 2018

Côté A. « Naissance d’un stage de soins palliatifs au premier cycle»
Présentation orale dans le cadre du Congrès international de soins palliatifs – McGill, Montréal, 21 octobre 2016

Carrier MC, Côté A. « Souffrance existentielle à l’ère de l’aide médicale à mourir » Présentation orale dans le cadre du Congrès international de soins palliatifs – McGill, Montréal, 19 octobre 2016

Côté A. « L’évaluation pronostic : entre art et science », Présentation orale dans le cadre du Colloque sur la médecine hospitalière – CPASS, Montréal, 4 février 2016

Drouin E., Vincent M., Daneault S., Côté A. « Les soins palliatifs – Un curriculum pour 300 étudiants ! Naissance d’un curriculum au premier cycle », Présentation orale dans le cadre de la Conférence canadienne sur l’éducation médicale – CCEM, Montréal, 16 avril 2016.

Côté A. « Loi sur les soins de fin de vie : de l’importance d’une interdisciplinarité pour de meilleurs soins », Assemblée générale de l’Association des intervenants en soins spirituels du Québec, Québec, 30 octobre 2015.

Côté A. « Loi sur les soins de fin de vie : entre l’espoir et la crainte pour l’avenir des soins palliatifs », Symposium étudiant sur la médecine familiale, Sherbrooke, 19 septembre 2015.